Dose intensity of mitomycin C in adjuvan
β
Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima; Osahiko Abe; Masato Fujisaki; Y
π
Article
π
1994
π
John Wiley and Sons
π
English
β 521 KB
Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer